U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274163) titled 'Ambispective Registry of Patients Affected by Lung Cancer' on Nov. 27.
Brief Summary: Lung cancer is one of the most common cancers and the leading cause of cancer-related death. It is often diagnosed late, and there are different types of lung cancer. Today, many patients benefit from targeted therapies and immunotherapy, which have improved survival.
This study will create an ambispective clinical registry of all lung cancer patients treated at Policlinico San Matteo.
The registry will collect data from 2019 to 2035 to better understand: 10-year overall survival, how the disease progresses over time, how patients respond to trea...